Magnus Björkholm

Publications
CV
Public outreach and news

Articles

Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025;26(5):2209
Targeting Tumor Microenvironment Interactions in Chronic Lymphocytic Leukemia Using Leukotriene Inhibitors
Sadeghi L; Merrien M; Bjorkholm M; Osterborg A; Sander B; Claesson H-E; Wright APH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2025;114(2):334-342
Loss in Overall and Quality-Adjusted Life Expectancy for Patients With Chronic-Phase Chronic Myeloid Leukemia
Chen EY-T; Dahlen T; Stenke L; Bjorkholm M; Hao S; Dickman PW; Clements MS
Article: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2024;174:106871
Expression and putative biological roles of lipoxygenases and leukotriene receptors in leukemia and lymphoma
Claesson H-E; Sjoberg J; Xu D; Bjorkholm M
Article: HAEMATOLOGICA. 2024;109(7):2250-2255
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden
Rognvaldsson S; Thorsteinsdottir S; Syriopoulou E; Sverrisdottir I; Turesson I; Eythorsson E; Oskarsson JT; Long TE; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Olafsson I; Thorsteinsdottir I; Aspelund T; Gislason GK; Olafsson A; Sigurdsson JK; Hultcrantz M; Durie BGM; Harding S; Bjorkholm M; Landgren O; Love TJ; Kristinsson SY
Article: MED. 2024;5(6):583-602.e5
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Arffman M; Meriranta L; Autio M; Holte H; Jorgensen J; Brown P; Jyrkkio S; Jerkeman M; Drott K; Fluge O; Bjorkholm M; Karjalainen-Lindsberg M-L; Beiske K; Pedersen MO; Leivonen S-K; Leppa S
Article: LEUKEMIA. 2024;38(5):1081-1085
Childbirth rates in women with myeloproliferative neoplasms
Landtblom AR; Andersson TM-L; Johansson ALV; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: LEUKEMIA. 2022;36(10):2461-2467
Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms-a nationwide population-based study of 342 pregnancies in Sweden
Landtblom AR; Andersson TM-L; Johansson ALV; Wendel SB; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: ACTA ONCOLOGICA. 2022;61(6):764-772
Reproductive history, as measured by parity, age at first birth and sex of offspring, and cancer-specific survival after a haematological malignancy
Johansson ALV; Dickman PW; Eloranta S; Bjorkholm M
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2022;41(1):173
GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma
Fang Z; Zhang N; Yuan X; Xing X; Li X; Qin X; Liu Z; Neo S; Liu C; Kong F; Bjorkholm M; Fan Y; Xu D
Article: BLOOD. 2022;139(12):1863-1877
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
Meriranta L; Alkodsi A; Pasanen A; Lepisto M; Mapar P; Blaker YN; Jorgensen J; Karjalainen-Lindsberg M-L; Fiskvik I; Mikalsen LTG; Autio M; Bjorkholm M; Jerkeman M; Fluge O; Brown P; Jyrkkio S; Holte H; Pitkanen E; Ellonen P; Leppa S
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;108(2):145-153
Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study
Steingrimsson V; Lund SH; Dickman PW; Weibull CE; Bjorkholm M; Landgren O; Kristinsson SY
Article: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2021;156:106575
Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells
Xia C; Sadeghi L; Straat K; Merrien M; Wright AP; Sander B; Xu D; Osterborg A; Bjorkholm M; Claesson H-E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(2):275-282
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
Jonsdottir G; Bjorkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(1):137-144
Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study
Rognvaldsson S; Aspelund T; Thorsteinsdottir S; Turesson I; Bjorkholm M; Landgren O; Kristinsson SY
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(1):92-103
Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: Trends in Sweden with the changing treatment landscape
Borgsten F; Gatopoulou X; Pisini M; Tambour M; Schain F; Jones CV; Kwok KHM; Batyrbekova N; Bjorkholm M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(6):774-782
Comorbidities in multiple myeloma and implications on survival: A population-based study
Sverrisdottir IS; Rognvaldsson S; Thorsteinsdottir S; Gislason GK; Aspelund T; Turesson I; Bjorkholm M; Gregersen H; Hveding Blimark C; Landgren O; Kristinsson SY
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(3):380-388
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
Baldursdottir TR; Love TJ; Gislason GK; Bjorkholm M; Mellqvist U-H; Lund SH; Blimark CH; Turesson I; Hultcrantz M; Landgren O; Kristinsson SY
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(3):346-353
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era
Steingrimsson V; Gislason GK; Porsteinsdottir S; Rognvaldsson S; Gottfredsson M; Aspelund T; Turesson I; Bjorkholm M; Landgren O; Kristinsson SY
Article: LEUKEMIA. 2021;35(2):476-484
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients
Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: JOURNAL OF CANCER. 2021;12(13):3853-3861
Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas
Xing X; Yuan X; Liu T; Dai M; Fan Y; Liu C; Straat K; Bjorkholm M; Xu D
Article: FRONTIERS IN ONCOLOGY. 2020;10:598872
Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures
Xia C; Olsen TK; Zirakzadeh AA; Almamoun R; Sjoholm LK; Dahlstrom J; Sjoberg J; Claesson H-E; Johnsen JI; Winqvist O; Xu D; Ekstrom TJ; Bjorkholm M; Straat K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(5):547-554
A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival
Steingrimsson V; Gislason GK; Aspelund T; Turesson I; Bjorkholm M; Landgren O; Kristinsson SY
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2020;527(2):425-431
JAK2 inhibition in JAK2^V617F-bearing leukemia cells enriches CD34⁺ leukemic stem cells that are abolished by the telomerase inhibitor GRN163L
Dahlstrom J; Xia C; Xing X; Yuan X; Bjorkholm M; Xu D
Article: CELL DEATH AND DIFFERENTIATION. 2020;27(6):1862-1877
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer
Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Straat K; Kong F; Zhao S; Bjorkholm M; Xu D
Article: BLOOD ADVANCES. 2020;4(9):1906-1915
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
Leppa S; Jorgensen J; Tierens A; Meriranta L; Ostlie I; Brown PDN; Fagerli U-M; Larsen TS; Mannisto S; Munksgaard L; Maisenholder M; Vasala K; Meyer P; Jerkeman M; Bjorkholm M; Fluge O; Jyrkklo S; Liestol K; Ralfkiaer E; Spetalen S; Beiske K; Karjalainen-Lindsberg M-L; Holte H
Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2020;18(1):184
The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females
Sun Q; Liu J; Cheng G; Dai M; Liu J; Qi Z; Zhao J; Li W; Kong F; Liu G; Bjorkholm M; Xu D
Article: HAEMATOLOGICA. 2020;105(5):1339-1350
An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma
Record J; Sendel A; Kritikou JS; Kuznetsov NV; Brauner H; He M; Nagy N; Oliveira MMS; Griseti E; Haase CB; Dahlstrom J; Boddul S; Wermeling F; Thrasher AJ; Liu C; Andersson J; Claesson H-E; Winqvist O; Burns SO; Bjorkholm M; Westerberg LS
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):448-454
Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden
Hultcrantz M; Landtblom AR; Andreasson B; Samuelsson J; Dickman PW; Kristinsson SY; Bjorkholm M; Andersson TM-L
Article: HAEMATOLOGICA. 2020;105(4):1067-1073
Fractures and survival in multiple myeloma: results from a population-based study
Thorsteinsdottir S; Gislason G; Aspelund T; Sverrisdottir I; Landgren O; Turesson I; Bjorkholm M; Kristinsson SY
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;188(5):685-691
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
Lagerlof I; Holte H; Glimelius I; Bjorkholm M; Enblad G; Erlanson M; Fluge O; Fohlin H; Fossa A; Goldkuhl C; Gustavsson A; Johansson A-S; Linderoth J; Nome O; Palma M; Akesson L; Ostenstad B; Raud C; Glimelius B; Molin D
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(6):614-619
Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population-based cohort study in Sweden and Norway
Schain F; Vago E; Song C; He J; Liwing J; Lofgren C; Bjorkholm M
Article: JAMA ONCOLOGY. 2019;5(9):1293-1301
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Landgren O; Hofmann JN; McShane CM; Santo L; Hultcrantz M; Korde N; Mailankody S; Kazandjian D; Murata K; Thoren K; Ramanathan L; Dogan A; Rustad E; Lu SX; Akhlaghi T; Kristinsson SY; Bjorkholm M; Devlin S; Purdue MP; Pfeiffer RM; Turesson I
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208
Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients
Weibull CE; Bjorkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;186(1):37-44
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
Sverrisdottir IS; Lund SH; Turesson I; Bjorkholm M; Goldin LR; Landgren O; Kristinsson SY
Article: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2019;37(5):301.e1-301.e10
The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Straat K; Bjorkholm M; Ma L; Xu D
Article: CELL DEATH & DISEASE. 2019;10(2):76
ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells
Wu Y; Li X; Yu J; Bjorkholm M; Xu D
Article: CANCER LETTERS. 2018;434:33-41
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma
Yu J; Yuan X; Sjoholm L; Liu T; Kong F; Ekstrom TJ; Bjorkholm M; Xu D
Article: LEUKEMIA. 2018;32(10):2203-2210
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
Landtblom AR; Bower H; Andersson TM-L; Dickman PW; Samuelsson J; Bjorkholm M; Kristinsson SY; Hultcrantz M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(26):2718-2725
Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators
Weibull CE; Johansson ALV; Eloranta S; Smedby KE; Bjorkholm M; Lambert PC; Dickman PW; Glimelius I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):106-114
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphomaA population-based study from Sweden
Bjorkholm M; Weibull CE; Eloranta S; Smedby KE; Glimelius I; Dickman PW
Article: ANNALS OF INTERNAL MEDICINE. 2018;168(5):317-325
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study
Hultcrantz M; Bjorkholm M; Dickman PW; Landgren O; Derolf AR; Kristinsson SY; Andersson TML
Article: ANNALS OF HEMATOLOGY. 2018;97(1):63-72
MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia
Zhang X; Li B; Yu J; Dahlstrom J; Anh NT; Bjorkhom M; Xu D
Article: BLOOD ADVANCES. 2017;1(25):2392-2398
The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study
Jonsdottir G; Lund SH; Bjorkholm M; Turesson I; Hultcrantz M; Porwit A; Jethava YS; Landgren O; Kristinsson SY
Article: ONCOGENE. 2017;36(32):4619-4628
Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells
Madapura HS; Nagy N; Ujvari D; Kallas T; Krohnke MCL; Amu S; Bjorkholm M; Stenke L; Mandal PK; McMurray JS; Keszei M; Westerberg LS; Cheng H; Xue F; Klein G; Klein E; Salamon D
Article: EBIOMEDICINE. 2017;21:104-116
Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes
Liang X; Yuan X; Yu J; Wu Y; Li K; Sun C; Li S; Shen L; Kong F; Jia J; Bjorkholm M; Xu D
Article: ONCOTARGET. 2017;8(14):23120-23129
The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma
Yuan X; Cheng G; Yu J; Zheng S; Sun C; Sun Q; Li K; Lin Z; Liu T; Li P; Xu Y; Kong F; Bjorkholm M; Xu D
Article: NURSE EDUCATION IN PRACTICE. 2017;23:8-14
Assessing nursing students' knowledge and skills in performing venepuncture and inserting peripheral venous catheters
Ahlin C; Klang-Soderkvist B; Johansson E; Bjorkholm M; Lofmark A
Article: FASEB JOURNAL. 2017;31(2):491-504
Human 15-lipoxygenase-1 is a regulator of dendritic-cell spreading and podosome formation
Han H; Liang X; Ekberg M; Kritikou JS; Brunnstrom A; Pelcman B; Matl M; Miao X; Andersson M; Yuan X; Schain F; Parvin S; Melin E; Sjoberg J; Xu D; Westerberg LS; Bjorkholm M; Claesson H-E
Article: ANNALS OF HEMATOLOGY. 2017;96(2):261-269
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
Lindqvist EK; Landgren O; Lund SH; Turesson I; Hultcrantz M; Goldin L; Bjorkholm M; Kristinsson SY
Article: BLOOD. 2016;128(23):2655-2665
Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells
Vardaki I; Sanchez C; Fonseca P; Olsson M; Chioureas D; Rassidakis G; Ullen A; Zhivotovsky B; Bjorkholm M; Panaretakis T
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;97(4):387-392
Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence
Gunnarsson N; Sandin F; Hoglund M; Stenke L; Bjorkholm M; Lambe M; Olsson-Stromberg U; Richter J; Sjalander A
Article: ANNALS OF HEMATOLOGY. 2016;95(11):1825-1832
TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations
Dahlstrom J; Liu T; Yuan X; Saft L; Ghaderi M; Wei YB; Lavebratt C; Li P; Zheng C; Bjorkholm M; Xu D
Article: ANNALS OF INTERNAL MEDICINE. 2016;165(3):161-166
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia A Population-Based Cohort Study
Dahlen T; Edgren G; Lambe M; Hoglund M; Bjorkholm M; Sandin F; Sjalander A; Richter J; Olsson-Stromberg U; Ohm L; Back M; Stenke L
Article: LEUKEMIA. 2016;30(7):1562-1567
Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia
Gunnarsson N; Hoglund M; Stenke L; Wallberg-Jonsson S; Sandin F; Bjorkholm M; Dreimane A; Lambe M; Markevarn B; Olsson-Stromberg U; Wadenvik H; Richter J; Sjalander A
Article: TRANSFUSION. 2016;56(6):1622-1627
Blood donation and risk of polycythemia vera
Edgren G; Nyren O; Hultcrantz M; Nielsen KR; Pedersen OBV; Bjorkholm M; Rostgaard K; Hjalgrim H
Article: ONCOTARGET. 2016;7(22):31972-31979
The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population
Yuan X; Meng Y; Li P; Ge N; Kong F; Yang L; Bjorkholm M; Zhao S; Xu D
Article: ONCOTARGET. 2016;7(18):25826-25835
The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients
Yuan X; Liu C; Wang K; Liu L; Liu T; Ge N; Kong F; Yang L; Bjorkholm M; Fan Y; Zhao S; Xu D
Article: ANNALS OF HEMATOLOGY. 2016;95(6):871-879
Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study
Kjellander C; Bjorkholm M; Kallman O; Giske CG; Weibull CE; Love TJ; Landgren O; Kristinsson SY
Article: NATURE REVIEWS DISEASE PRIMERS. 2016;2:16010
Acute myeloid leukaemia
Khwaja A; Bjorkholm M; Gale RE; Levine RL; Jordan CT; Ehninger G; Bloomfield CD; Estey E; Burnett A; Cornelissen JJ; Scheinberg DA; Bouscary D; Linch DC
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(3):542-547
Brain tumors in patients with myotonic dystrophy: a population-based study
Gadalla SM; Pfeiffer RM; Kristinsson SY; Bjorkholm M; Landgren O; Greene MH
Article: BLOOD CANCER JOURNAL. 2016;6(2):e390
Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life
Bower H; Andersson TM-L; Bjorkholm M; Dickman PW; Lambert PC; Derolf AR
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(2):175-180
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
Dahlen T; Kalin M; Cederlund K; Nordlander A; Bjorkholm M; Ljungman P; Blennow O
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(4):337-344
Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma
Weibull CE; Eloranta S; Smedby KE; Bjorkholm M; Kristinsson SY; Johansson ALV; Dickman PW; Glimelius I
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I; Ekberg S; Jerkeman M; Chang ET; Bjorkholm M; Andersson TML; Smedby KE; Eloranta S
Article: ONCOTARGET. 2015;6(35):38079-38092
Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells
Ci X; Li B; Ma X; Kong F; Zheng C; Bjorkholm M; Jia J; Xu D
Article: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2015;121(Pt A):122-130
Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells
Han H; Xue-Franzen Y; Miao X; Nagy E; Li N; Xu D; Sjoberg J; Bjorkholm M; Claesson H-E
Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2015;100:33-40
Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes
Mahshid Y; Markoutsa S; Dincbas-Renqvist V; Sueruen D; Christensson B; Sander B; Bjorkholm M; Sorg BL; Radmark O; Claesson H-E
Article: JOURNAL OF CLINICAL ONCOLOGY. 2015;33(20):2288-2295
Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study
Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM-L; Derolf AR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Bjorkholm M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;169(5):683-688
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
Gunnarsson N; Stenke L; Hoglund M; Sandin F; Bjorkholm M; Dreimane A; Lambe M; Markevarn B; Olsson-Stromberg U; Richter J; Wadenvik H; Wallvik J; Sjalander A
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2015;101(6):563-568
Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case-control study from Sweden
Kristinsson SY; Gao Y; Bjorkholm M; Lund SH; Sjoberg J; Caporaso N; Goldin LR; Landgren O
Article: LEUKEMIA & LYMPHOMA. 2015;56(5):1385-1391
Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib
Ohm L; Lundqvist A; Dickman P; Hoglund M; Persson U; Stenke L; Carlsson KS; Bjorkholm M
Article: JAMA ONCOLOGY. 2015;1(2):168-174
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Bjorkholm M; Landgren O; Kristinsson SY
Article: ONCOTARGET. 2015;6(7):4888-4900
The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression
Zhang X; Li B; de Jonge N; Bjorkholm M; Xu D
Article: HAEMATOLOGICA. 2015;100(1):107-113
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Blimark C; Holmberg E; Mellqvist U-H; Landgren O; Bjoekholm M; Hultcrantz M; Kjellander C; Turesson I; Kristinsson SY
Article: PLOS ONE. 2014;9(12):e113977
Setae from Larvae of the Northern Processionary Moth (Thaumetopoea pinivora, TP) Stimulate Proliferation of Human Blood Lymphocytes In Vitro
Holm G; Andersson M; Ekberg M; Fagrell B; Sjoberg J; Bottai M; Bjorkholm M
Article: ONCOTARGET. 2014;5(23):12428-12439
TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
Wang K; Liu T; Ge N; Liu L; Yuan X; Liu J; Kong F; Wang C; Ren H; Yan K; Hu S; Xu Z; Bjrkholm M; Fan Y; Zhao S; Liu C; Xu D
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2014;80(6):424-431
Dendritic Cells in Bone Marrow at Diagnosis and after Chemotherapy in Adult Patients with Acute Myeloid Leukaemia
Derolf AR; Laane E; Bjorklund E; Saft L; Bjorkholm M; Porwit A
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2014;12(11):1816-1821
Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma
Hultcrantz M; Pfeiffer RM; Bjorkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
Article: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2014;138(9):1203-1209
Megakaryocytic Morphology and Clinical Parameters in Essential Thrombocythemia, Polycythemia Vera, and Primary Myelofibrosis With and Without JAK2 V617F
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Article: EPIDEMIOLOGY. 2014;25(5):742-748
The Application of Cure Models in the Presence of Competing Risks A Tool for Improved Risk Communication in Population-Based Cancer Patient Survival
Eloranta S; Lambert PC; Andersson TM-L; Bjorkholm M; Dickman PW
Article: ANNALS OF HEMATOLOGY. 2014;93(9):1491-1498
Self-reported fertility in long-term survivors of acute myeloid leukemia
Branvall E; Derolf AR; Johansson E; Hultcrantz M; Bergmark K; Bjorkholm M
Article: CLINICAL DRUG INVESTIGATION. 2014;34(7):483-489
Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden
Lundberg J; Hoglund M; Bjorkholm M; Akerborg O
Article: BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2014;27(2):141-153
Leukemic transformation in myeloproliferative neoplasms: Therapy-related or unrelated?
Bjorkholm M; Hultcrantz M; Derolf AR
Article: ONCOTARGET. 2014;5(7):1829-1836
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
Wang K; Liu T; Liu L; Liu J; Liu C; Wang C; Ge N; Ren H; Yan K; Hu S; Bjorkholm M; Fan Y; Xu D
Article: PLOS ONE. 2014;9(4):e94442
Promoter Polymorphism in the Serotonin Transporter ( 5-HTT) Gene Is Significantly Associated with Leukocyte Telomere Length in Han Chinese
Li P; Liu T; Liu J; Zhang Q; Lou F; Kong F; Cheng G; Bjorkholm M; Zheng C; Xu D
Article: PLOS ONE. 2014;9(3):e91031
Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
Taskinen M; Louhimo R; Koivula S; Chen P; Rantanen V; Holte H; Delabie J; Karjalainen-Lindsberg M-L; Bjorkholm M; Fluge O; Pedersen LM; Fjorden K; Jerkeman M; Eriksson M; Hautaniemi S; Leppa S
Article: PLOS ONE. 2014;9(1):e85085
Interleukin-4-Mediated 15-Lipoxygenase-1 Trans-Activation Requires UTX Recruitment and H3K27me3 Demethylation at the Promoter in A549 Cells
Han H; Xu D; Liu C; Claesson H-E; Bjorkholm M; Sjoberg J
Article: PLOS ONE. 2013;8(11):e79851
Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis
Gadalla SM; Pfeiffer RM; Kristinsson SY; Bjorkholm M; Hilbert JE; Moxley RTIII; Landgren O; Greene MH
Article: ONCOGENE. 2013;32(36):4203-4213
Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Bjorkholm M; Jia J; Xu D
Article: CANCER. 2013;119(16):3076-3083
Multidrug resistance in relapsed acute myeloid leukemia: Evidence of biological heterogeneity
Patel C; Stenke L; Varma S; Lindberg ML; Bjorkholm M; Sjoberg J; Viktorsson K; Lewensohn R; Landgren O; Gottesman MM; Gillet J-P
Article: BLOOD. 2013;122(7):1284-1292
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
Hoglund M; Sandin F; Hellstrom K; Bjoreman M; Bjorkholm M; Brune M; Dreimane A; Ekblom M; Lehmann S; Ljungman P; Malm C; Markevarn B; Myhr-Eriksson K; Ohm L; Olsson-Stromberg U; Sjalander A; Wadenvik H; Simonsson B; Stenke L; Richter J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(4):509-516
Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study
Shah A; Andersson TM-L; Rachet B; Bjorkholm M; Lambert PC
Article: BRITISH JOURNAL OF CANCER. 2013;108(11):2272-2280
Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects
Liu T; Liang X; Li B; Bjorkholm M; Jia J; Xu D
Article: HAEMATOLOGICA. 2013;98(6):875-880
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Vianelli N; Palandri F; Polverelli N; Stasi R; Joelsson J; Johansson E; Ruggeri M; Zaja F; Cantoni S; Catucci AE; Candoni A; Morra E; Bjorkholm M; Baccarani M; Rodeghiero F
Article: ANNALS OF ONCOLOGY. 2013;24(5):1385-1392
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
Holte H; Leppa S; Bjorkholm M; Fluge O; Jyrkkio S; Delabie J; Sundstrom C; Karjalainen-Lindsberg M-L; Erlanson M; Kolstad A; Fossa A; Ostenstad B; Lofvenberg E; Nordstrom M; Janes R; Pedersen LM; Anderson H; Jerkeman M; Eriksson M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(11):1435-1441
Temporal Trends in Mortality From Diseases of the Circulatory System After Treatment for Hodgkin Lymphoma: A Population-Based Cohort Study in Sweden (1973 to 2006)
Eloranta S; Lambert PC; Sjoberg J; Andersson TML; Bjorkholm M; Dickman PW
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013;45(2):112-116
Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection
Cherif H; Axdorph U; Kalin M; Bjorkholm M
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2013;88(1):60-65
Patterns of survival in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: A population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005
Kristinsson SY; Eloranta S; Dickman PW; Andersson TM-L; Turesson I; Landgren O; Bjorkholm M
Article: HEMATOLOGY. 2013;18(1):8-13
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up
Ejerblad E; Kvasnicka HM; Thiele J; Andreasson B; Bjorkholm M; Lofvenberg E; Markevarn B; Merup M; Nilssson L; Palmblad J; Samuelsson J; Birgegard G
Article: PLOS ONE. 2012;7(12):e52703
Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/Demethylation
Liu C; Xu D; Han H; Fan Y; Schain F; Xu Z; Claesson H-E; Bjorkholm M; Sjoberg J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2012;89(5):395-402
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy
Riihijarvi S; Nurmi H; Holte H; Bjorkholm M; Fluge O; Pedersen LM; Rydstrom K; Jerkeman M; Eriksson M; Leppa S
Article: CANCER RESEARCH. 2012;72(20):5348-5362
Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro, Ex Vivo, and In Vivo in the 5T33MM Mouse Model
Kharaziha P; De Raeve H; Fristedt C; Li Q; Gruber A; Johnsson P; Kokaraki G; Panzar M; Laane E; Osterborg A; Zhivotovsky B; Jernberg-Wiklund H; Grander D; Celsing F; Bjorkholm M; Vanderkerken K; Panaretakis T
Article: HAEMATOLOGICA. 2012;97(10):1603-1607
Thrombosis is associated with inferior survival in multiple myeloma
Kristinsson SY; Pfeiffer RM; Bjorkholm M; Schulman S; Landgren O
Article: INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2012;44(9):1531-1540
Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells
Li P; Hou M; Lou F; Bjorkholm M; Xu D
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(24):2995-3001
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Hultcrantz M; Kristinsson SY; Andersson TM-L; Landgren O; Eloranta S; Derolf AR; Dickman PW; Bjorkholm M
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2012;12:86
Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S; Lambert PC; Andersson TML; Czene K; Hall P; Bjorkholm M; Dickman PW
Article: HAEMATOLOGICA. 2012;97(6):854-858
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
Kristinsson SY; Tang M; Pfeiffer RM; Bjorkholm M; Goldin LR; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2012;88(5):422-430
Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
Kjellander C; Bjorkholm M; Cherif H; Kalin M; Giske CG
Article: INFECTION. 2012;40(1):81-85
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia
Bjorkholm M; Kalin M; Grane P; Celsing F
Article: EXPERIMENTAL CELL RESEARCH. 2012;318(3):169-176
Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line
Liu C; Schain F; Han H; Xu D; Andersson-Sand H; Forsell P; Claesson H-E; Bjorkholm M; Sjoberg J
Article: BLOOD. 2012;119(4):990-996
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009
Sjoberg J; Halthur C; Kristinsson SY; Landgren O; Nygell UA; Dickman PW; Bjorkholm M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(2):179-183
Familial Aggregation of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Goldin LR; Kristinsson SY; Liang XS; Derolf AR; Landgren O; Bjorkholm M
Article: ONCOIMMUNOLOGY. 2012;1(1):18-27
Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection
Rosen A; Bergh A-C; Gogolak P; Evaldsson C; Myhrinder AL; Hellqvist E; Rasul A; Bjorkholm M; Jansson M; Mansouri L; Liu A; Teh BT; Rosenquist R; Klein E
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2011;306(22):2480-2486
Cancer Risk Among Patients With Myotonic Muscular Dystrophy
Gadalla SM; Lund M; Pfeiffer RM; Gortz S; Mueller CM; Moxley RTIII; Kristinsson SY; Bjoerkholm M; Shebl FM; Hilbert JE; Landgren O; Wohlfahrt J; Melbye M; Greene MH
Article: BLOOD. 2011;118(24):6284-6291
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
Lindqvist EK; Goldin LR; Landgren O; Blimark C; Mellqvist U-H; Turesson I; Wahlin A; Bjorkholm M; Kristinsson SY
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2011;174(8):969-976
A Method to Visualize and Adjust for Selection Bias in Prevalent Cohort Studies
Torner A; Dickman P; Duberg A-S; Kristinsson S; Landgren O; Bjorkholm M; Svensson A
Article: BLOOD. 2011;118(15):4086-4092
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
Article: JOURNAL OF PATHOLOGY. 2011;225(2):203-211
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells
Liu L; Liu C; Lou F; Zhang G; Wang X; Fan Y; Yan K; Wang K; Xu Z; Hu S; Bjorkholm M; Xu D
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(21):2897-2903
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Kristinsson SY; Bjorkholm M; Hultcrantz M; Derolf AR; Landgren O; Goldin LR
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(18):2514-2520
Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
Bjorkholm M; Ohm L; Eloranta S; Derolf A; Hultcrantz M; Sjoberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(17):2410-2415
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
Bjorkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegard G; Linder O; Malm C; Markevarn B; Nilsson L; Samuelsson J; Granath F; Landgren O
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(11):2688-2694
A population-based assessment of mortality and morbidity patterns among patients with thymoma
Gadalla SM; Rajan A; Pfeiffer R; Kristinsson SY; Bjorkholm M; Landgren O; Giaccone G
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;407(3):599-604
Premature senescence of T cells in long-term survivors of renal transplantation
Li P; Tian C; Ge N; Wang H; Liu L; Lou F; Bjorkholm M; Xu D
Article: BLOOD. 2011;117(5):1670-1672
Infection in infancy and subsequent risk of developing lymphoma in children and young adults
Goldin LR; Landgren O; Kristinsson SY; Bjorkholm M; Paltiel O
Article: SEMINARS IN HEMATOLOGY. 2011;48(1):46-54
Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance
Kristinsson SY; Bjorkholm M; Schulman S; Landgren O
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(34):5081-5087
Survival Patterns in Patients With Hodgkin's Lymphoma With a Pre-Existing Hospital Discharge Diagnosis of Autoimmune Disease
Landgren O; Pfeiffer RM; Kristinsson SY; Bjorkholm M
Article: BLOOD. 2010;116(15):2651-2655
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study
Kristinsson SY; Tang M; Pfeiffer RM; Bjorkholm M; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Article: HAEMATOLOGICA. 2010;95(7):1216-1220
Autoimmunity and the risk of myeloproliferative neoplasms
Kristinsson SY; Landgren O; Samuelsson J; Bjorkholm M; Goldin LR
Article: BLOOD. 2010;115(24):4991-4998
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
Kristinsson SY; Pfeiffer RM; Bjorkholm M; Goldin LR; Schulman S; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Article: MOLECULAR CANCER. 2010;9:132
Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer
Li W; Zeng J; Li Q; Zhao L; Liu T; Bjorkholm M; Jia J; Xu D
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2010;102(8):557-567
Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom Macroglobulinemia
Kristinsson SY; Koshiol J; Bjorkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(6):918-924
Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study
Andersson TM-L; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Bjorkholm M; Dickman PW
Article: GASTROENTEROLOGY. 2010;138(3):981-992
The Histone Demethylase RBP2 Is Overexpressed in Gastric Cancer and Its Inhibition Triggers Senescence of Cancer Cells
Zeng J; Ge Z; Wang L; Li Q; Wang N; Bjorkholm M; Jia J; Xu D
Article: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2010;133(2):271-280
Connective Tissue Growth Factor Is Expressed in Malignant Cells of Hodgkin Lymphoma but Not in Other Mature B-Cell Lymphomas
Birgersdotter A; Baumforth KRN; Wei W; Murray PG; Sjoberg J; Bjorkholm M; Porwit A; Ernberg I
Article: EXPERIMENTAL HEMATOLOGY. 2010;38(2):116-123
Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236
Andersson E; Schain F; Sjoberg J; Bjorkholm M; Claesson H-E
Article: FASEB JOURNAL. 2010;24(2):579-586
Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase
Ge Z; Li W; Wang N; Liu C; Zhu Q; Bjorkholm M; Gruber A; Xu D
Article: HAEMATOLOGICA. 2009;94(12):1714-1720
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
Kristinsson SY; Bjorkholm M; Andersson TM-L; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(9):2147-2150
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden
Kristinsson SY; Bjorkholm M; Goldin LR; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Article: BRITISH JOURNAL OF CANCER. 2009;101(8):1393-1401
Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma
Birgersdotter A; Baumforth KRN; Porwit A; Sjoberg J; Wei W; Bjorkholm M; Murray PG; Ernberg I
Article: HAEMATOLOGICA. 2009;94(10):1460-1464
Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia
Toro JR; Blake PW; Bjoerkholm M; Kristinsson SY; Wang Z; Landgren O
Article: CANCER CAUSES & CONTROL. 2009;20(8):1441-1449
Timing of births and endometrial cancer risk in Swedish women
Pfeiffer RM; Mitani A; Landgren O; Ekbom A; Kristinsson SY; Bjorkholm M; Biggar RJ; Brinton LA
Article: HAEMATOLOGICA. 2009;94(9):1259-1265
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden
Kristinsson SY; Dickman PW; Wilson WH; Caporaso N; Bjorkholm M; Landgren O
Article: JOURNAL OF PATHOLOGY. 2009;218(4):419-427
FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27^kip1
Zeng J; Wang L; Li Q; Li W; Bjorkholm M; Jia J; Xu D
Article: BLOOD. 2009;114(4):791-795
Risk of plasma cell and lymphoproliferative disorders among 14 621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
Landgren O; Kristinsson SY; Goldin LR; Caporaso NE; Blimark C; Mellqvist U-H; Wahlin A; Bjorkholm M; Turesson I
Article: LAKARTIDNINGEN. 2009;106(30-31):1891-1894
[Pine processionary moth--a big health problem in southern Gotland. Results of a questionnaire study].
Holm G; Sjöberg J; Ekstrand C; Björkholm M; Granath F; Ekbom A; Larsson S
Article: AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. 2009;297(1):L196-L203
15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells
Liu C; Xu D; Liu L; Schain F; Brunnstrom A; Bjorkholm M; Claesson H-E; Sjoberg J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2009;146(1):91-94
Highly increased familial risks for specific lymphoma subtypes
Goldin LR; Bjorkholm M; Kristinsson SY; Turesson I; Landgren O
Article: HAEMATOLOGICA. 2009;94(5):647-653
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia
Goldin LR; Bjorkholm M; Kristinsson SY; Turesson I; Landgren O
Article: JOURNAL OF CLINICAL ONCOLOGY. 2009;27(12):2073-2080
Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden
Kristinsson SY; Derolf AR; Edgren G; Dickman PW; Bjoerkholm M
Article: BLOOD. 2009;113(16):3666-3672
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
Derolf AR; Kristinsson SY; Andersson TM-L; Landgren O; Dickman PW; Bjorkholm M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2009;101(7):488-497
Activation of Telomerase by Human Cytomegalovirus
Straat K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Bjoerkholm M; Sjoberg J; Soederberg-Naucler C; Xu D
Article: CLINICAL LYMPHOMA AND MYELOMA. 2009;9(1):19-22
Novel Aspects Pertaining to the Relationship of Waldenstrom's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and Hypoglobulinemia
McMaster ML; Kristinsson SY; Turesson I; Bjorkholm M; Landgren O
Article: SUPPORTIVE CARE IN CANCER. 2009;17(2):137-143
Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia
Johansson E; Engervall P; Bjorvell H; Hast R; Bjorkholm M
Article: BMC IMMUNOLOGY. 2009;10:2
High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes
Mahshid Y; Lisy M-R; Wang X; Spanbroek R; Flygare J; Christensson B; Bjorkholm M; Sander B; Habenicht AJR; Claesson H-E
Article: GASTROENTEROLOGY. 2009;136(1):91-98
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.
Gao Y; Kristinsson SY; Goldin LR; Björkholm M; Caporaso NE; Landgren O
Article: CLINICAL LYMPHOMA AND MYELOMA. 2008;8(6):340-347
Differential Expression of Cysteinyl Leukotriene Receptor 1 and 15-Lipoxygenase-1 in Non-Hodgkin Lymphomas
Schain F; Schain D; Mahshid Y; Liu C; Porwit A; Xu D; Claesson H-E; Sundstrom C; Bjorkholm M; Sjoberg J
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(10):2285-2293
Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma
Schain F; Tryselius Y; Sjoberg J; Porwit A; Backman L; Malec M; Xu D; Vockerodt M; Baumforth KRN; Wei W; Murray PG; Bjorkholm M; Claesson H-E
Article: BLOOD. 2008;112(9):3582-3586
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Kristinsson SY; Fears TR; Gridley G; Turesson I; Mellqvist U-H; Bjoerkholm M; Landgren O
Article: JOURNAL OF CLINICAL ONCOLOGY. 2008;26(30):4958-4965
Survival Patterns Among Lymphoma Patients With a Family History of Lymphoma
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Bjorkholm M; Caporaso NE; Landgren O
Article: BLOOD. 2008;112(8):3052-3056
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients:: a population-based study in Sweden
Kristinsson SY; Bjorkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Article: BLOOD. 2008;112(6):2199-2204
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
Landgren O; Goldin LR; Kristinsson SY; Helgadottir EA; Samuelsson J; Bjorkholm M
Article: FEBS JOURNAL. 2008;275(16):4222-4234
Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo -: Novel insight into the inflammatory features of classical Hodgkin lymphoma
Claesson H-E; Griffiths WJ; Brunnstrorm A; Schain F; Andersson E; Feltenmark S; Johnson HA; Porwit A; Sjoberg J; Bjorkholm M
Article: LEUKEMIA & LYMPHOMA. 2008;49(7):1279-1291
Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia
Derolf AR; Bjorklund E; Mazur J; Bjorkholm M; Porwit A
Article: AMERICAN JOURNAL OF PATHOLOGY. 2008;173(1):195-204
Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells
Baumforth KRN; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap L-F; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CBJ; Murray PG
Article: CLINICAL CANCER RESEARCH. 2008;14(12):3722-3728
CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells
Li W; Ge Z; Liu C; Liu Z; Bjorkholm M; Jia J; Xu D
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2008;80(6):477-482
CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).
Björkholm M; Andersson T; Ahlbom A; Ösby E
Article: INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. 2008;5(2):87-91
TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
Palmblad J; Björkholm M; Kutti J; Lärfars G; Löfvenberg E; Markevärn B; Merup M; Mauritzson N; Westin J; Samuelsson J; Birgegård G
Article: PSYCHO-ONCOLOGY. 2008;17(4):338-346
Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument
Wettergren L; Sprangers M; Bjorkholm M; Langius-Eklof A
Article: BRITISH JOURNAL OF CANCER. 2008;98(5):1001-1005
Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma
Andersson A; Enblad G; Tavelin B; Bjorkholm M; Linderoth J; Lagerlof I; Merup M; Sender M; Malmer B
Article: CANCER LETTERS. 2008;260(1-2):28-36
Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues
Li W; Li L; Liu Z; Liu C; Liu Z; Straat K; Bjorkholm M; Jia J; Xu D
Article: PLOS ONE. 2008;3(1):e1446
Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene
Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Straat K; Bjorkholm M; Xu D
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(2):680-685
Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells
Feltenmark S; Gautam N; Brunnstrom A; Griffiths W; Backman L; Edenius C; Lindbom L; Bjorkholm M; Claesson H-E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2007;79(6):468-476
The expression of cytosolic phospholipase A₂ and biosynthesis of leukotriene B₄ in acute myeloid leukemia cells
Runarsson G; Feltenmark S; Forsell PKA; Sjoberg J; Bjorkholm M; Claesson H-E
Article: SUPPORTIVE CARE IN CANCER. 2007;15(12):1393-1398
Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication
Cherif H; Martling C-R; Hansen J; Kalin M; Bjorkholm M
Article: INTERNATIONAL JOURNAL OF CANCER. 2007;121(10):2260-2266
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003
Turesson I; Linet MS; Bjorkholm M; Kristinsson SY; Goldin LR; Caporaso NE; Landgren O
Article: LEUKEMIA & LYMPHOMA. 2007;48(10):2042-2053
Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern
Birgersdotter A; Baumforth KRN; Porwit A; Sundblad A; Falk KI; Wei W; Sjoeberg J; Murray PG; Bjoerkholm M; Ernberg I
Article: MOLECULAR CANCER RESEARCH. 2007;5(8):793-800
The opposing effect of hypoxia-inducible factor-2α on expression of telomerase reverse transcriptase
Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Bjoerkholm M; Liu Z; Xu D
Article: ANNALS OF ONCOLOGY. 2007;18(6):1085-1089
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
Bjoerkholm M; Hagberg H; Holte H; Kvaloy S; Teerenhovi L; Anderson H; Cavallin-Stahl E; Myhre J; Pertovaara H; Oest A; Nilsson B; Oesby E
Article: CANCER RESEARCH. 2007;67(6):2626-2631
The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3
Liu C; Fang X; Ge Z; Jalink M; Kyo S; Bjorkhom M; Gruber A; Sjoberg J; Xu D
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007;353(4):999-1003
Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA
Jalink M; Ge Z; Liu C; Bjorkholm M; Gruber A; Xu D
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2006;77(4):288-292
Antifungal therapy in patients with hematological malignancies:: how to avoid overtreatment?
Cherif H; Kalin M; Bjorkholm M
Article: LEUKEMIA & LYMPHOMA. 2006;47(9):1768-1773
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase
Olsson-Stromberg U; Hoglund M; Bjorkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Lofvenberg E; Malm C; Nilsson P-G; Paul C; Rodjer S; Stenke L; Tidefeldt U; Turesson I; Uden A-M; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Article: ANNALS OF ONCOLOGY. 2006;17(8):1290-1295
A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone:: with special reference to older patients
Landgren O; Axdorph U; Fears TR; Porwit-MacDonald A; Wedelin C; Bjorkholm M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2006;77(1):61-66
Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura
Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Bjorkholm M
Article: HAEMATOLOGICA. 2006;91(6):833-836
The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy
Laane E; Derolf AR; Bjorklund E; Mazur J; Everaus H; Soderhall S; Bjorkholm M; Porwit-MacDonald A
Article: CANCER. 2006;106(11):2397-2405
A phase II trial of pegylated interferon α-2b therapy for polycythemia vera and essential thrombocythemia -: Feasibility, clinical and biologic effects, and impact, on quality of life
Samuelsson J; Hasselbalch H; Bruserud O; Temerinac S; Brandberg Y; Merup M; Linder O; Bjorkholm M; Pahl HL; Birgegard G
Article: HAEMATOLOGICA. 2006;91(2):215-222
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies
Cherif H; Johansson E; Björkholm M; Kalin M
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(2):449-452
Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma
Landgren O; Björkholm M; Montgomery SM; Hjalgrim H; Sjöberg J; Goldin LR; Askling J
Article: VACCINE. 2006;24(1):75-81
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases
Cherif H; Landgren A; Konradsen HB; Kalin M; Björkholm M
Article: MOLECULAR AND CELLULAR BIOLOGY. 2006;26(1):230-237
Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telornerase reverse transcriptase expression/telomerase activation induced by proliferation
Ge Z; Liu C; Björkholm M; Gruber A; Xu DW
Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(12):1765-1768
Do steroids increase lymphoma risk?: A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Article: QUALITY OF LIFE RESEARCH. 2005;14(10):2329-2333
Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma' survivors
Wettergren L; Björkholm M; Langius-Eklöf A
Article: CLINICAL CANCER RESEARCH. 2005;11(12):4331-4337
Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues
Fan YD; Liu ZX; Fang XL; Ge Z; Ge N; Jia Y; Sun P; Lou FL; Björkholm M; Gruber A; Ekman P; Xu DW
Article: BONE MARROW TRANSPLANTATION. 2005;35(12):1141-1148
Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience
Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B
Article: GUT. 2005;54(5):617-622
Risk of haematopoietic cancer in patients with inflammatory bowel disease
Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
Article: VIRUS GENES. 2005;30(3):323-330
EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells
Bandobashi K; Liu AQ; Nagy N; Kis LL; Nishikawa J; Björkholm M; Klein G; Klein E
Article: HAEMATOLOGICA. 2005;90(4):505-515
A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol
Bjorkholm M; Fagrell B; Przybelski R; Winslow N; Young M; Winslow RM
Article: BLOOD. 2005;105(7):2908-2915
High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma
Björck E; Ek S; Landgren O; Jerkeman M; Ehinger M; Björkholm M; Borrebaeck CAK; Porwit-MacDonald A; Nordenskjöld M
Article: ANNALS OF HEMATOLOGY. 2005;84(3):150-158
Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis
Wikman A; Axdorph U; Gryfelt G; Gustafsson L; Björkholm M; Lundahl J
Article: BLOOD. 2005;105(3):1274-1279
Leukotriene B₄ plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells
Runarsson G; Liu AQ; Mahshid Y; Feltenmark S; Pettersson A; Klein E; Björkholm M; Claesson HE
Article: ACTA HAEMATOLOGICA. 2005;113(3):155-162
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia:: Long-term follow-up
Simonsson B; Öberg G; Björeman M; Björkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Löfvenberg E; Malm C; Olsson K; Olsson-Strömberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén AM; Wahlin A; Vilén L; Weis-Bjerrum O
Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2005;20(9):769-773
Sick leave due to depressive disease: Not a risk factor for the development of malignant lymphoma
Nordström M; Granath F; Björkholm M; Ekbom A
Article: QUALITY OF LIFE RESEARCH. 2004;13(8):1369-1379
Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma
Wettergren L; Björkholm M; Axdorph U; Langius-Eklöf A
Article: LEUKEMIA. 2004;18(10):1630-1636
Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping
Malec M; van der Velden VHJ; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
Article: ONCOGENE. 2004;23(44):7441-7447
Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix
Zhang AJ; Wang JL; Zheng BY; Fang XL; Ångström T; Liu C; Li XD; Erlandsson F; Björkholm M; Nordenskjörd M; Gruber A; Wallin KL; Xu DW
Article: HAEMATOLOGICA. 2004;89(9):1072-1081
Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes
Lindvall C; Furge K; Björkholm M; Guo X; Haab B; Blennow E; Nordenskjöld M; Teh BT
Article: EXPERIMENTAL CELL RESEARCH. 2004;297(1):61-67
Transcriptional regulation of 15-lipoxygenase expression by promoter methylation
Liu C; Xu DW; Sjöberg J; Forsell P; Björkholm M; Claesson HE
Article: HAEMATOLOGICA. 2004;89(6):679-685
Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma
Malec M; Söderqvist M; Sirsjö A; MacNamara B; Lewin N; Sjöberg J; Björkholm M; Porwit-MacDonald A
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(6):664-673
A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
Article: HAEMATOLOGICA. 2004;89(5):520-527
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders
Birgegård G; Björkholm M; Kutti J; Lärfars G; Löfvenberg E; Markevärn B; Merup M; Palmblad J; Mauritzson N; Westin J; Samuelsson J
Article: SUPPORTIVE CARE IN CANCER. 2004;12(2):99-105
Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia - a randomized study
Johansson E; Björkholm M; Björvell H; Hast R; Takolander R; Olofsson P; Backman L; Weitzberg E; Engervall P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2004;124(4):474-480
Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial
Löfgren C; Paul C; Åström M; Hast R; Hedenius M; Lerner R; Liliemark J; Nilsson I; Rödjer S; Simonsson B; Stockelberg D; Tidefelt U; Björkholm M
Article: HEMATOLOGY JOURNAL. 2004;5(1):69-76
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas
Landgren O; MacDonald AP; Tani E; Czader M; Grimfors G; Skoog L; Öst A; Wedelin C; Axdorph U; Svedmyr E; Björkholm M
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(11-12):855-859
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies
Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
Article: HEMATOLOGY JOURNAL. 2004;5(6):462-466
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Öberg G
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2004;36(8):593-600
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Article: ACTA ONCOLOGICA. 2004;43(3):297-301
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma
Ösby E; Askling J; Landgren O; Dickman PW; Ekbom A; Björkholm M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;123(5):810-818
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
Juliusson G; Höglund M; Karlsson K; Löfgren C; Möllgård L; Paul C; Tidefelt U; Björkholm M
Article: LEUKEMIA. 2003;17(9):1827-1833
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease
Hast R; Hellström-Lindberg E; Ohm L; Björkholm M; Celsing F; Dahl JM; Dybedal I; Gahrton G; Lindberg G; Lerner R; Linder O; Löfvenberg E; Nilsson-Ehle H; Paul C; Samuelsson J; Tangen JM; Tidefelt U; Turesson I; Wahlin A; Wallvik J; Winquist I; Öberg G; Bernell P
Article: QUALITY OF LIFE RESEARCH. 2003;12(5):545-554
Individual quality of life in long-term survivors of Hodgkin's lymphoma - a comparative study
Wettergren L; Björkholm M; Axdorph U; Bowling A; Langius-Eklöf A
Article: LEUKEMIA & LYMPHOMA. 2003;44(7):1229-1234
Molecular cytogenetic approach to the diagnosis of splenic lymphoma:: A case report of blastoid mantle cell lymphoma
Björck E; Landgren O; Schoumans J; Christensson B; Björkholm M; MacDonald AP; Nordenskjöld M
Article: BLOOD. 2003;101(10):3840-3848
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
Ösby E; Hagberg H; Kvaloy S; Teerenhovi L; Anderson H; Cavallin-Ståhl E; Holte H; Myhre J; Pertovaara H; Björkholm M
Article: LEUKEMIA RESEARCH. 2003;27(4):323-328
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia
Gruber A; Björkholm M; Brinch L; Evensen S; Gustavsson B; Hedenus M; Juliusson G; Löfvenberg E; Nesthus I; Simonsson B; Sjo M; Stenke L; Tangen JM; Tidefelt U; Udén AM; Paul C; Liliemark J
Article: HAEMATOLOGICA. 2003;88(4):438-444
Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis
Landgren O; Algernon C; Axdorph U; Nilsson B; Wedelin C; Porwit-MacDonald A; Grimfors G; Björkholm M
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2003;72(4):940-948
Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome
Zhang AJ; Zheng CY; Hou M; Lindvall C; Li KJ; Erlandsson F; Björkholm M; Gruber A; Blennow E; Xu DW
Article: HEMATOLOGY JOURNAL. 2003;4(4):248-252
Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III.
Lundin J; Osterborg A; Björkholm M; Björkstrand B; Celsing F; Hjalmar V; Linder O; Luthman M; Merup M; Tidefelt U; Mellstedt H; Myeloma Group of Central Sweden
Article: HEMATOLOGY JOURNAL. 2003;4(6):420-426
Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Article: HEMATOLOGY JOURNAL. 2003;4(5):336-341
Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphoma.
Ahlberg R; MacNamara B; Andersson M; Zheng C; Svensson A; Holm G; Hansson M; Porwit-MacDonald A; Björkholm M; Sundblad A
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2002;13(7):448-454
Granulocyte function in elderly patients receiving chemotherapy for aggressive non-Hodgkin's lymphoma. Effect of granulocyte colony-stimulating factor.
Osby E; Björkholm M; Lundahl J; Forslid J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(4):1048-1054
Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase -: a report from the Swedish CML Group
Axdorph U; Stenke L; Grimfors G; Carneskog J; Hansen J; Linder O; Ljungman P; Löfvenberg E; Malm C; Simonsson B; Turesson I; Vilén L; Udén AM; Björkholm M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(3):748-754
High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia
Hallböök H; Simonsson B; Ahlgren T; Björkholm M; Carneskog J; Grimfors G; Hast R; Karlsson K; Kimby E; Lerner R; Linder O; Linderholm M; Löfvenberg E; Malm C; Nilsson PG; Paul C; Stenke L; Stockelberg D; Tidefelt U; Turesson I; Uden-Blome AM; Vilen L; Wahlin A; Winquist I; Smedmyr B
Article: BLOOD. 2002;100(3):768-773
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
Lundin J; Kimby E; Björkholm M; Broliden PA; Celsing F; Hjalmar V; Möllgård L; Rebello P; Hale G; Waldmann H; Mellstedt H; Österborg A
Article: GENES CHROMOSOMES & CANCER. 2002;34(3):269-275
Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas
Zhang AJ; Zheng CY; Hou M; Lindvall C; Wallin KL; Ångström T; Yang XY; Hellström AC; Blennow E; Björkholm M; Zetterberg A; Gruber A; Xu DW
Article: HAEMATOLOGICA. 2002;87(6):596-601
Parental longevity and survival in elderly patients with Hodgkin's lymphoma
Landgren O; Askling J; Dickman PW; Ösby E; Axdorph U; Ekbom A; Björkholm M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2002;68(6):376-381
Long-term follow-up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy
Öberg G; Killander A; Björeman M; Gahrton G; Grimfors G; Gruber A; Hast R; Lerner R; Liliemark J; Mattson S; Paul C; Simonsson B; Stalfelt AM; Stenke L; Tidefelt U; Udén AM; Björkholm M
Article: APMIS. 2002;110(5):379-390
T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects
Axdorph U; Porwit-MacDonald A; Sjoberg J; Grimfors G; Bjorkholm M
Article: EXPERIMENTAL CELL RESEARCH. 2002;274(1):25-34
The histone deacetylase inhibitor trichostatin a derepresses the telomerase reverse transcriptase (hTERT) gene in human cells
Hou M; Wang XB; Popov N; Zhang AJ; Zhao XY; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu DW
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;116(4):765-773
Expression of the signal transduction molecule ζ in peripheral and tumour-associated lymphocytes in Hodgkin's disease in relation to the Epstein-Barr virus status of the tumour cells
Sjöberg J; Andersson M; Garcia C; Palucka KA; Björkholm M; Porwit-MacDonald A
Article: MEDICAL ONCOLOGY. 2002;19(2):79-86
Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia.
Merup M; Kutti J; Birgergård G; Mauritzson N; Björkholm M; Markevärn B; Maim C; Westin J; Palmblad J; Swedish National Study Group on Chronic Myeloproli
Article: HAEMATOLOGICA. 2001;86(11):1158-1164
Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements
Lindvall C; Nordenskjöld M; Porwit A; Björkholm M; Blennow E
Article: SUPPORTIVE CARE IN CANCER. 2001;9(8):619-624
Outpatient parenteral antibiotic therapy in patients with haematological malignancies -: A pilot study of an early discharge strategy
Johansson E; Björkholm M; Wredling R; Kalin M; Engervall P
Article: ANTI-CANCER DRUGS. 2001;12(10):859-864
Quantification of doxorubicin in plasma -: a comparative study of capillary and venous blood sampling
Palm C; Björk O; Björkholm M; Eksborg S
Article: LEUKEMIA & LYMPHOMA. 2001;42(5):1055-1065
Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease
Axdorph U; Porwit-MacDonald A; Grimfors G; Björkholm M
Article: JOURNAL OF HUMAN VIROLOGY. 2001;4(5):227-237
Epstein-Barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins
Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;67(3):189-193
Antibody reactivities to skeletal muscle proteins in a patient with λ light chain secreting multiple myeloma, generalised amyloidosis and rhabdomyolysis
Sundblad A; Porwit A; Ostad M; Nennesmo I; Holm G; Ösby E; Borg K; Björkholm M
Article: INTERNATIONAL JOURNAL OF CANCER. 2001;95(3):184-188
Interleukin-10 gene promoter polymorphisms in multiple myeloma
Zheng C; Huang DR; Liu L; Wu RH; Glas SB; Österborg A; Björkholm M; Holm G; Yi Q; Sundblad A
Article: LEUKEMIA. 2001;15(5):716-727
Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL
Malec M; Björklund E; Söderhäll S; Mazur J; Sjögren AM; Pisa P; Björkholm M; Porwit-MacDonald A
Article: LAKARTIDNINGEN. 2001;98(16):1899-1903
[Prophylactic and empirical treatment of mycoses in neutropenic fever. Report and comments on meta-analysis].
Kalin M; Björkholm M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2001;98(7):3826-3831
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
Xu DW; Popov N; Hou M; Wang Q; Björkholm M; Gruber A; Menkel AR; Henriksson M
Article: BRITISH JOURNAL OF CANCER. 2001;84(5):621-625
Telomerase activity in plasma cell dyscrasias
Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A
Article: MEDICAL ONCOLOGY. 2001;18(4):269-275
Oral etoposide in patients with hematological malignancies - A clinical and pharmacokinetic study
Ösby E; Liliemark E; Björkholm M; Liliemark J
Article: MEDICAL ONCOLOGY. 2001;18(2):137-140
Reproducibility of tumor response evaluation in patients with high-grade malignant non-Hodgkin's lymphoma
Ösby E; Taube A; Cavallin-Ståhl E; Hagberg H; Björkholm M
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2001;33(4):316-319
Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia
Björkholm M; Runarsson G; Celsing F; Kalin M; Petrini B; Engervall P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;112(1):216-218
Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma
Zheng CY; Huang DR; Liu L; Björkholm M; Holm G; Yi Q; Sundblad A
Article: CANCER RESEARCH. 2000;60(22):6230-6235
Frequent amplification of the Telomerase Reverse Transcriptase gene in human tumors
Zhang AJ; Zheng CY; Lindvall C; Hou M; Ekedahl J; Lewensohn R; Yan ZQ; Yang XY; Henriksson M; Blennow E; Nordenskjöld M; Zetterberg A; Björkholm M; Gruber A; Xu DW
Article: ANNALS OF ONCOLOGY. 2000;11(11):1405-1411
Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease
Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
Article: ONCOGENE. 2000;19(45):5123-5133
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
Xu DW; Wang Q; Gruber A; Björkholm M; Chen ZG; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Article: MEDICAL ONCOLOGY. 2000;17(3):174-178
Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease
Landgren O; Axdorph U; Jacobsson H; Johansson B; Grimfors G; Björkholm M
Article: HAEMATOLOGICA. 2000;85(8):832-838
Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Article: GENES CHROMOSOMES & CANCER. 2000;28(4):415-424
RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13)
Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
Article: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2000;91(1):41-42
Caesarean section in previously untreated acute promyelocytic leukaemia -: Report of two patients
Celsing F; Ekman G; Granström L; Johnsson H; Björkholm M
Article: JOURNAL OF HUMAN VIROLOGY. 2000;3(3):125-136
Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle
Teramoto N; Gogolák P; Nagy N; Maeda A; Kvarnung K; Björkholm M; Klein E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;109(1):39-45
Interleulkin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma
Zheng CY; Huang DR; Bergenbrant S; Sundblad A; Österborg A; Björkholm M; Holm G; Yi Q
Article: HEMATOLOGY JOURNAL. 2000;1(2):95-101
Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH.
Nordgren A; Farnebo F; Björkholm M; Sahlén S; Porwit-MacDonald A; Osby E; Kytölä S; Larsson C; Nordenskjöld M; Blennow E
Article: HEMATOLOGY JOURNAL. 2000;1(2):102-110
V-region-specific alterations of serum IgM production in multiple myeloma of IgG class.
Sundblad A; Coutinho A; Björkholm M; Holm G
Article: BRITISH JOURNAL OF CANCER. 1999;81(7):1182-1187
Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function
Axdorph U; Porwit-MacDonald A; Sjöberg J; Grimfors G; Ekman M; Wang W; Biberfeld P; Björkholm M
Article: JOURNAL OF INTERNAL MEDICINE. 1999;246(3):293-297
The measurement of venous haematocrit in patients with polycythaemia vera
Andréasson B; Wahlström E; Jacobsson S; Björkholm M; Samuelsson J; Birgegård G; Wadenvik H; Kutti J
Article: JOURNAL OF CHEMOTHERAPY. 1999;11(4):278-286
Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: A randomized, single-center phase II trial
Engervall P; Kalin M; Dornbusch K; Björkholm M
Article: BONE MARROW TRANSPLANTATION. 1999;24(2):169-172
Arterial blood oxygenation, maximum exercise capacity and oxygen transport in patients before and after autologous peripheral blood progenitor cell transplantation
Gruber A; Brundin T; Björkholm M
Article: BRITISH JOURNAL OF CANCER. 1999;80(8):1156-1161
Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms
Xu D; Gruber A; Björkholm M; Peterson C; Pisa P
Article: LAKARTIDNINGEN. 1999;96(17):2092-2095
[HTLV-1 induced adult T-cell leukemia. The first case now documented in Sweden].
Jacobsson B; Celsing F; Andersson S; Björkholm M
Article: LEUKEMIA & LYMPHOMA. 1999;32(3-4):309-316
Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia
Palucka KA; Knaust E; Xu DW; Macnamara B; Porwit-MacDonald A; Gruber A; Peterson C; Björkholm M; Pisa P
Article: ACTA ONCOLOGICA. 1999;38(4):475-480
Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation
Wettergren L; Langius A; Björkholm M; Björvell H
Article: ANNALS OF ONCOLOGY. 1998;9(11):1213-1217
Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
Celsing E; Widell S; Merk K; Bernell P; Grimfors G; Hedlund A; Liliemark J; Svedmyr E; Ösby E; Björkholm M
Article: FEBS LETTERS. 1998;434(3):295-299
On the expression of cytosolic calcium-independent phospholipase A₂ (88 kDa) in immature and mature myeloid cells and its role in leukotriene synthesis in human granulocytes
Forsell PKAL; Runarsson G; Ibrahim M; Björkholm M; Claesson HE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1998;30(5):489-493
Low incidence of candidaemia among neutropenic patients treated for haematological diseases
Chryssanthou E; Kalin M; Engervall P; Petrini B; Björkholm M
Article: BONE MARROW TRANSPLANTATION. 1997;20(6):497-502
Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation - A prospective study
Wettergren L; Langius A; Bjorkholm M; Bjorvell H
Article: INFECTION. 1997;25(1):2-7
Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern
Engervall P; Granstrom M; Andersson B; Kalin M; Bjorkholm M
Article: ACTA ONCOLOGICA. 1997;36(4):444-446
Disseminated tuberculosis treated with amikacin in a patient with acute myelocytic leukemia
Engervall P; Kalin M; Bjorkholm M
Article: ANTI-CANCER DRUGS. 1997;8(1):42-47
Plasma pharmacokinetics of idarubicin and its 13-dihydro metabolite - A comparison of bolus versus 2 h infusion during a 3 day course
Eksborg S; Bjorkholm M; Hast R; Fagerlund E
Article: JOURNAL OF CHEMOTHERAPY. 1996;8(5):382-386
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients
Engervall P; Gunther G; Ljungman P; Lonnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Bjorkholm M
Article: CANCER LETTERS. 1996;106(1):97-100
Higher in vivo protein binding of etoposide in children compared with adult cancer patients
Liliemark E; Soderhall S; Sirzea F; Gruber A; Osby E; Bjorkholm M; Zhou R; Peterson C; Liliemark J
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1996;31(6):604-611
Factors influencing the response to interferon therapy in chronic hepatitis C - Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells
Grander D; Hultcrantz R; Weiland O; Xu B; Sangfelt O; Bjorklund AC; Befrits R; Bjorkholm M; Gruber A; Kinnman N; Reichard O; Widell A; Einhorn S
Article: LANCET. 1996;347(9013):1432-1438
Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia
Fenaux P; Binet JL; Leporrier M; Travade P; Piguet H; Linassier C; Desablens B; Dreyfus B; Brizard CP; Murgue B; Russet T; Souteyrand P; Johnson S; Phillips MJ; Hiddemann W; Smith A; Roath S; Loffler H; Bjorkholm M; Osby E; Emmerich B; Coiffier B; Thiel E; Knauf W; Juliusson G; Marcus R; Prentice AG; Copplestone JA; Freund M; Milligan PW; Winfield D; Yin J; Hellriegel KP; Hossfeld DK; Kimby E; Burnett AK; Lister TA; Lucie N; Kanz L; Lerner R; Lindemalm C; Child A; Hamblin T; Oscier D; Smith JG; Singer RJ; Parker A; Whittaker J; Wyld P; Smith AG
Article: BLOOD. 1996;87(8):3360-3367
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage
Scuderi R; Palucka KA; Pokrovskaja K; Bjorkholm M; Wiman KG; Pisa P
Article: LEUKEMIA & LYMPHOMA. 1996;21(1-2):71-78
Treatment of Hodgkin's disease: the Swedish National Care Programme experience.
Glimelius B; Enblad G; Kalkner M; Gustavsson A; Jakobsson M; Branehog I; Lenner P; Bjorkholm M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(4):840-846
Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients
Bergenbrant S; Yi Q; Osterborg A; Bjorkholm M; Osby E; Mellstedt H
Article: LEUKEMIA. 1996;10(3):558-563
Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice
Palucka AK; Scuderi R; Porwit A; Jeha S; Gruber A; Bjorkholm M; Beran M; Pisa P
Article: APMIS. 1996;104(2):153-160
Polyomavirus-infected oligodendrocytes and macrophages within astrocytes in progressive multifocal leukoencephalopathy (PML) - Case report
Mesquita R; Bjorkholm M; Ekman M; Bogdanovic G; Biberfeld P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(2):393-400
Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease
Sjoberg J; AguilarSantelises M; Sjogren AM; Pisa EK; Ljungdahl A; Bjorkholm M; Jondal M; Mellstedt H; Pisa P
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(1):71-76
Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): Association with malignant transformation
Isaksson E; Bjorkholm M; Holm G; Johansson B; Nilsson B; Mellstedt H; Osterborg A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1995;91(4):838-845
CLINICAL-SIGNIFICANCE OF SERUM CYTOKINE PATTERNS DURING START OF FEVER IN PATIENTS WITH NEUTROPENIA
ENGERVALL P; ANDERSSON B; BJORKHOLM M
Article: ANNALS OF ONCOLOGY. 1995;6(9):895-899
Fired versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease - A prospective randomized trial
Bjorkholm M; Axdorph U; Grimfors G; Merk K; Johansson B; Landgren O; Svedmyr E; Mellstedt H; Holm G
Article: BLOOD. 1995;86(4):1493-1501
LOCAL SUPPRESSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXICITY IN BIOPSIES OF EBV-POSITIVE HODGKINS-DISEASE
FRISAN T; SJOBERG J; DOLCETTI R; BOIOCCHI M; DE RE V; CARBONE A; BRAUTBAR C; BATTAT S; BIBERFELD P; ECKMAN M; OST O; CHRISTENSSON B; SUNDSTROM C; BJORKHOLM M; PISA P; MASUCCI MG
Article: LEUKEMIA & LYMPHOMA. 1995;18(5-6):435-442
MULTIDRUG-RESISTANCE (MDR1) GENE-EXPRESSION IN PERIPHERAL BLASTS FROM PATIENTS WITH ACUTE-LEUKEMIA ONLY RARELY INCREASES DURING DISEASE PROGRESSION AFTER COMBINATION CHEMOTHERAPY
GRUBER A; ARESTROM I; ALBERTIONI F; BJORKHOLM M; PETERSON C
Article: PEDIATRIC RESEARCH. 1995;38(1):7-10
STUDIES OF THE ORGAN DISTRIBUTION IN MICE OF TENIPOSIDE LIPOSOMES DESIGNED FOR TREATMENT OF DISEASES IN THE MONONUCLEAR PHAGOCYTIC SYSTEM
LILIEMARK E; LILIEMARK J; KALLBERG N; BJORKHOLM M; SJOSTROM B; PETERSON C
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(1):19-23
MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON
BJORKHOLM M; LILIEMARK J; GAHRTON G; GRIMFORS G; GRUBER A; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; LJUNGMAN P; LONNQVIST B; PALMBLAD J; PAUL C; PETTERSON C; SIMONSSON B; STALFELT AM; STENKE L; SUNDSTROM C; TIDEFELT U; UDEN AM; OBERG G; OST A
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1995;90(3):585-594
DIVERSE EXPRESSION OF CYTOSOLIC PHOSPHOLIPASE-A(2), 5-LIPOXYGENASE AND PROSTAGLANDIN-H SYNTHASE-2 IN ACUTE PRE-B-LYMPHOCYTIC LEUKEMIA-CELLS
FELTENMARK S; RUNARSSON G; LARSSON P; JAKOBSSON PJ; BJORKHOLM M; CLAESSON HE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;54(5):321-328
INCREASE OF MONOCYTES PREDICTS MOBILIZATION OF PERIPHERAL STEM AND PROGENITOR CELLS AFTER CHEMOTHERAPY FOLLOWED BY G-CSF ADMINISTRATION
HANSSON M; SVENSSON A; ENGERVALL P; BJORKHOLM M; GRUBER A; SODERSTROM T
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;54(4):226-234
MONITORING OF ENDOTOXIN, INTERLEUKIN-6 AND C-REACTIVE PROTEIN SERUM CONCENTRATIONS IN NEUTROPENIC PATIENTS WITH FEVER
ENGERVALL P; GRANSTROM M; ANDERSSON B; BJORKHOLM M
Article: JOURNAL OF HOSPITAL INFECTION. 1995;29(4):275-286
CHANGE OF CENTRAL VENOUS CATHETER DRESSINGS TWICE A WEEK IS SUPERIOR TO ONCE A WEEK IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
ENGERVALL P; RINGERTZ S; HAGMAN E; SKOGMAN K; BJORKHOLM M
Article: LANCET. 1995;345(8950):603-607
FREQUENT PATIENT-TO-PATIENT TRANSMISSION OF HEPATITIS-C VIRUS IN A HEMATOLOGY WARD
ALLANDER T; GRUBER A; NAGHAVI M; BEYENE A; SODERSTROM T; BJORKHOLM M; GRILLNER L; PERSSON MAA
Article: JOURNAL OF INTERNAL MEDICINE. 1995;237(2):205-209
LEUKOCYTE DOUBLING TIME IS A USEFUL PREDICTOR OF PROGRESSION-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC-LEUKEMIA
AXDORPH U; NILSSON BI; NILSSON BR; BJORKHOLM M
Article: CANCER RESEARCH, THERAPY AND CONTROL. 1995;4(3):223-229
ANTIBODIES TO EPSTEIN-BARR-VIRUS IN RELATION TO CLINICAL CHARACTERISTICS OF UNTREATED PATIENTS WITH HODGKINS-DISEASE
MERK K; LENNETTE E; HOLM G; JOHANSSON B; MASUCCI G; GRIMFORS G; KLEIN G; BJORKHOLM M
Show more

All other publications

Letter: ACTA ONCOLOGICA. 2023;62(12):1942-1944
Splenectomised Hodgkin lymphoma patients: does severe pneumococcal disease pose a problem today and what is the best long-term strategy?
Weibull CE; Sjoberg J; Dickman PW; Bjorkholm M
Letter: HAEMATOLOGICA. 2022;107(1):284-286
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Shah UA; Rognvaldsson S; Derkach A; Bjorkholm M; Turesson I; David Y; Hultcrantz M; Tan C; Hassoun H; Korde N; Lesokhin A; Mailankody S; Kristinsson SY; Landgren CO
Letter: HAEMATOLOGICA. 2020;105(11):2679-2681
Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls
Rognvaldsson S; Steingrimsson V; Turesson I; Bjorkholm M; Landgren O; Kristinsson SY
Letter: ANNALS OF HEMATOLOGY. 2020;99(2):375-376
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Schain F; Dominicus A; Borgsten F; Mozart M; Bjorkholm M
Letter: BLOOD. 2019;134(4):407-410
Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and the United States
Bjorkholm M; Edgren G; Dickman PW
Review: CANCER EPIDEMIOLOGY. 2019;60:168-173
Loss in life expectancy and gain in life years as measures of cancer impact
Rutherford MJ; Andersson TM-L; Bjorkholm M; Lambert PC
Letter: HAEMATOLOGICA. 2018;103(9):e412-e415
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study
Thorsteinsdottir S; Dickman PW; Landgren O; Blimark C; Hultcrantz M; Turesson I; Bjorkholm M; Kristinsson SY
Letter: ANNALS OF INTERNAL MEDICINE. 2018;169(4):268
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms RESPONSE
Hultcrantz M; Bjorkholm M; Landgren O; Kristinsson SY; Andersson TML
Review: GASTROENTEROLOGY. 2018;155(2):374-382.e1
Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis
Mahadev S; Laszkowska M; Sundstrom J; Bjorkholm M; Lebwohl B; Green PHR; Ludvigsson JF
Corrigendum: ANNALS OF HEMATOLOGY. 2018;97(7):1299
MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia (vol 97, pg 63, 2018)
Zhang X; Li B; Yu J; Dahlstrom J; Anh NT; Bjorkholm M; Xu D
Review: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(2):237-244
Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival
Turesson I; Bjorkholm M; Blimark CH; Kristinsson S; Velez R; Landgren O
Letter: LEUKEMIA. 2017;31(8):1825-1827
No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden
Gunnarsson N; Hoglund M; Stenke L; Sandin F; Bjorkholm M; Dreimane A; Lambe M; Markevarn B; Olsson-Stromberg U; Wadenvik H; Richter J; Sjalander A
Corrigendum: LEUKEMIA RESEARCH. 2017;57:127
Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS) (Vol 13, 31, 1989)
Garcia C; Rosen A; Kimby E; Aguilar-Santelises M; Jondal M; Bjorkhilm M; Holm G; Mellstedt H
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(6):696-697
Population-Level Survival for Patients With Chronic Myeloid Leukemia: Higher Survival in Sweden Than Internationally Reply
Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
Letter: BLOOD CANCER JOURNAL. 2016;6(11):e501
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study
Pauly F; Fjorden K; Leppa S; Holte H; Bjorkholm M; Fluge O; Pedersen LM; Eriksson M; Isinger-Ekstrand A; Borrebaeck CAK; Jerkeman M; Wingren C
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(24):2851-2857
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):1829-1830
Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!
Korfel A; Chamberlain M; Neuwelt E; Thiel E; Doolittle N; Schlegel U; Dreyling M; Rubenstein J; Fischer L; Bjorkholm M; Martus P; Weller M; Glantz M
Letter: HAEMATOLOGICA. 2016;101(4):e145-e148
Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study
Jonsdottir G; Lund SH; Bjorkholm M; Turesson I; Wahlin A; Mailankody S; Blimark C; Hultcrantz M; Porwit A; Landgren O; Kristinsson SY
Letter: HAEMATOLOGICA. 2015;100(10):e402-e405
Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms
Dahlstrom J; Zhang X; Ghaderi M; Hultcrantz M; Bjorkholm M; Xu D
Letter: BLOOD. 2015;125(23):3665-3666
Survival in patients with familial and sporadic myeloproliferative neoplasms
Hultcrantz M; Lund SH; Landgren O; Samuelsson J; Goldin LR; Oddsson A; Bjorkholm M; Kristinsson SY
Letter: BLOOD. 2015;125(13):2174-2175
Population-based study on the impact of the familial form of Waldenstrom macroglobulinemia on overall survival
Steingrimsson V; Lund SH; Turesson I; Goldin LR; Bjorkholm M; Landgren O; Kristinsson SY
Review: CANCER MEDICINE. 2015;4(1):147-154
Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy
Hultcrantz M; Svensson T; Derolf AR; Kristinsson SY; Lindqvist EK; Ekbom A; Granath F; Bjorkholm M
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2014;167(5):724-726
Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia - very long follow-up
Rohatiner AZS; Smith ML; Spinelli O; Rambaldi A; Bassan R; di Bona E; Rodeghiero F; Raimondi R; Bjorkholm M; Johnson S; Newland AC; Cavenagh JD; Macdougall F; Waters R; Fitzgibbon J; Barbui T; Lister A
Letter: LEUKEMIA. 2014;28(8):1751-1754
Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse
Zhang X; Zhang Q; Dahlstrom J; Tran AN; Yang B; Gu Z; Ghaderi M; Porwit A; Jia J; Derolf A; Xu D; Bjorkholm M
Letter: HAEMATOLOGICA. 2014;99(8):1273-1276
Cancer survivorship programs: time for concerted action
Barbui T; Bjorkholm M; Gratwohl A
Letter: GENE. 2014;540(2):266-267
The absence of TERT promoter mutations in primary gastric cancer
Liu T; Liang X; Bjoerkholm M; Jia J; Xu D
Letter: BLOOD. 2013;122(3):460-461
No familial aggregation in chronic myeloid leukemia
Bjorkholm M; Kristinsson SY; Landgren O; Goldin LR
Letter: BLOOD. 2013;121(23):4807
Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1
Bjorkholm M; Sjoberg J; Nygell UA; Porwit A; Bjorck E
Published conference paper: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2013;13(2):187-190
Survival in Monoclonal Gammopathy of Undetermined Significance and Waldenstrom Macroglobulinemia
Kristinsson SY; Bjorkholm M; Landgren O
Letter: INTERNATIONAL JOURNAL OF CANCER. 2012;131(11):2718
Re: Risk of malignancy associated with Lyme disease: Still up in the air
Chang CM; Landgren O; Koshiol J; Bjorkholm M; Love TJ; Kristinsson SY
Letter: INTERNATIONAL JOURNAL OF CANCER. 2012;131(9):2208-2209
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden
Chang CM; Landgren O; Koshiol J; Bjoerkholm M; Loeve TJ; Kristinsson SY
Editorial: HAEMATOLOGICA. 2012;97(6):800-804
Optimizing investigator-led oncology research in Europe
Barbui T; Bjorkholm M; Gratwohl A
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2012;10(5):962-964
Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population-based study
Kristinsson SY; Goldin L; Turesson I; Hultcrantz M; Bjorkholm M; Landgren O
Review: ACTA HAEMATOLOGICA. 2012;127(3):173-177
Familial Aggregation of Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia with Solid Tumors and Myeloid Malignancies
Kristinsson SY; Goldin LR; Turesson I; Bjorkholm M; Landgren O
Review: CURRENT OPINION IN ONCOLOGY. 2011;23(5):421-428
How we treat elderly patients with Hodgkin lymphoma
Bjorkholm M; Svedmyr E; Sjoberg J
Corrigendum: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(3):285
CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis) (vol 80, pg 477, 2008)
Bjoerkholm M; Andersson T; Ahlbom A; Oesby E
Editorial: SCIENCE. 2010;328(5986):1641-1642
Tackling Two Diseases with HDL
Hansson GK; Bjorkholm M
Letter: ANNALS OF HEMATOLOGY. 2010;89(5):523-525
Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients
Kalin M; Kristinsson SY; Cherif H; Lebbad M; Bjorkholm M
Letter: LEUKEMIA & LYMPHOMA. 2009;50(11):1872-1874
Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?
Hallbook H; Bjorkholm M; Hagglund H; Smedmyr B
Review: HAEMATOLOGICA. 2009;94(11):1581-1589
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies
Kristinsson SY; Goldin LR; Bjorkholm M; Koshiol J; Turesson I; Landgren O
Letter: HAEMATOLOGICA. 2009;94(10):1468-1469
Autoimmunity and risk for Hodgkin's lymphoma by subtype
Kristinsson SY; Landgren O; Sjoberg J; Turesson I; Bjorkholm M; Goldin LR
Letter: HAEMATOLOGICA. 2009;94(8):1179-1181
Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance
Kristinsson SY; Goldin LR; Bjorkholm M; Turesson I; Landgren O
Review: GENOME MEDICINE. 2009;1(5):55
Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms
Goldin LR; Bjoerkholm M; Kristinsson SY; Samuelsson J; Landgren O
Published conference paper: CLINICAL LYMPHOMA AND MYELOMA. 2009;9(1):23-26
Genetics- and Immune-Related Factors in the Pathogenesis of Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia
Kristinsson SY; Koshiol J; Goldin LR; Bjorkholm M; Turesson I; Gridley G; McMaster ML; Landgren O
Letter: ANNALS OF HEMATOLOGY. 2009;88(2):173-175
Chronic myeloid leukemia presenting late in pregnancy. Report of a case and a questionnaire reflecting diversity in management options
Bjorkholm M; Ohm L; Stenke L
Meeting abstract: BLOOD. 2007;110(11):203A
Increased risk of monoclonal gammopathy of undetermined significance (MGUS) and lymphoproliferative tumors among 14689 first-degree relatives of 4488 MGUS patients in Sweden
Landgren O; Kristinsson SY; Goldin LR; Caporaso NE; Blimark C; Mellqvist U-H; Wahlin A; Bjorkholm M; Turesson I
Meeting abstract: BLOOD. 2007;110(11):209A
Increased risks of polycythemia vera (PV), essential Thrombocythemia (ET), and myelofibrosis (MF) among 24577 first-degree relatives of 11039 patients with chronic myeloproliferative disorders (MPD) in sweden.
Landgren O; Goldin LR; Kristinsson SY; Samuelsson J; Bjorkholm M
Letter: ANNALS OF ONCOLOGY. 2007;18(6):1122-1123
Suicide in multiple myeloma and acute myeloid leukaemia
Bjorkholm M; Hultcrantz M; Kristinsson S; Brandt L; Ekbom A; Derolf A
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(15):1993-1999
Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003
Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Bjorkholm M
Letter: HAEMATOLOGICA. 2006;91:170
Intractable myoclonus associated with anti-GluR3 antibodies after allogeneic bone marrow transplatation
Laane E; Porwit A; Bjorkholm M
Meeting abstract: BLOOD. 2006;108(11):2437
CNOP (Mitoxantrone) chemotherapy is inferior to CHOP (Doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (Review).
Bjorkholm M; Osby E; Andersson T; Ahlbom A
Meeting abstract: BLOOD. 2006;108(11):640A
Leukotrienes stimulate the release of cytokines and proliferation of Hodgkin Reed-Sternberg cells.
Sjoberg J; Schain F; Tryselius Y; Backman L; Malec M; Porwit-MacDonald A; Bjorkholm M; Claesson H-E
Letter: ANNALS OF HEMATOLOGY. 2006;85(10):731-733
Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma -: a 20-year follow-up
Bjoerkholm M; Celsing F; Johansson E
Letter: HAEMATOLOGICA. 2006;91(9):1281-1282
Limited effects on JAK2 mutational status after pegylated interferon α-2b therapy in polycythemia vera and essential thrombocythemia
Samuelsson J; Mutschler M; Birgegard G; Gram-Hansen P; Bjorkholm M; Pahl HL
Meeting abstract: BLOOD. 2005;106(11):258B-259B
G-CSF supported CHOP-14 with rituximab in patients <60 years with high-risk diffuse large B cell lymphoma (DLBCL).
Bernell P; Hedlund A; Bjorkholm M
Meeting abstract: BLOOD. 2005;106(11):931A
Incidence and risk factors for central nervous system manifestation in elderly patients with aggressive non-Hodgkin's lymphoma.
Ösby E; Hagberg H; Kvalöy S; Teerenhovi L; Anderson H; Cavallin-Stahl E; Holte H; Myhre J; Öst A; Pertovaara H; Björkholm M
Meeting abstract: BLOOD. 2005;106(11):525A
Prognosis in acute myeloid leukemia: A population-based study on 5,809 patients diagnosed in Sweden 1973-2001.
Derolf AR; Landgren O; Dickman P; Kristinsson SY; Bjorkholm M
Letter: ANNALS OF ONCOLOGY. 2005;16(5):838-840
Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial?
Landgren O; Andrén H; Nilsson B; Ekbom A; Björkholm M
Letter: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2005;53(2):357-358
Familial longevity: The older you are, the older your father may have been
Landgren O; Björkholm M; Granath F; Ekbom A
Review: CLINICAL LYMPHOMA AND MYELOMA. 2004;5(3):155-162
Treatment options in Waldenstrom's macroglobulinemia
Björkholm M
Meeting abstract: BLOOD. 2004;104(11):277A
Virus reactivation profile as assessed by PCR and serology pattern following first-line alemtuzumab (anti-CD52 monoclonal antibody, Campath®) therapy in patients with B-CLL.
Karlsson C; Dahl H; Linde A; Lundin J; Björkholm M; Mellstedt H; Osterborg A
Meeting abstract: BLOOD. 2004;104(11):662A
Improved prognosis in multiple myeloma-a population based study on 13,376 patients diagnosed in Sweden 1973-2001
Kristinsson SY; Landgren O; Dickman P; Derolf A; Bjorkholm M
Meeting abstract: BLOOD. 2004;104(11):425A
A phase II trial of pegylated interferon α-2b in polycythemia vera and essential thrombocythemia.: Clinical responses, effects on PRV-1 expression and impact on quality of life
Samuelsson J; Hasselbalch H; Bruserud O; Pahl H; Merup M; Linder O; Brandberg Y; Gram-Hansen P; Bjorkholm M; Ghanima W; Malm C; Markevarn B; Mourits-Andersen T; Johansson P; Nilsson L; Birgegard G
Published conference paper: CANCER RESEARCH. 2003;63(8):1743-1747
Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling:: Activation of the Epiregulin gene
Lindvall C; Hou M; Komurasaki T; Zheng CY; Henriksson M; Sedivy JM; Björkholm M; Teh BT; Nordenskjöld M; Xu DW
Review: SEMINARS IN ONCOLOGY. 2003;30(2):226-230
Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia:: A two-institution study
Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZA
Review: SEMINARS IN ONCOLOGY. 2003;30(2):116-120
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia:: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond W
Published conference paper: ANNALS OF ONCOLOGY. 2002;13:86-91
Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?
Carde P; Koscielny S; Franklin J; Axdorph U; Raemaekers J; Diehl V; Aleman B; Brosteanu O; Hasenclever D; Oberlin O; Bonvin N; Björkholm M
Letter: AMERICAN JOURNAL OF MEDICINE. 2001;110(4):329-330
Late infections after blood progenitor cell transplantation in patients with multiple myeloma
Steingrimsdottir H; Gruber A; Kalin M; Björkholm M
Published conference paper: CLINICAL CHEMISTRY. 2001;47(3):519-524
Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity
Hou M; Xu DW; Björkholm M; Gruber A
Meeting abstract: EUROPEAN JOURNAL OF CANCER. 1999;35:S43
Outpatient parenteral antibiotic therapy (OPAT) in patients with acute leukaemia (AL) and aggressive non-Hodgkin's lymphoma (NHL)
Johansson E; Björkholm M; Wredling R; Engervall P
Published conference paper: IMMUNOLOGY LETTERS. 1999;68(1):147-154
LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40
Klein E; Teramoto N; Gogolák P; Nagy N; Björkholm M
Letter: ANNALS OF ONCOLOGY. 1997;8(12):1281-1283
How much chemotherapy in advanced Hodgkin's disease?
Bjorkholm M
Review: LAKARTIDNINGEN. 1997;94(26-27):2454-2460
[Acute myeloid leukemia. Achievements and challenges in the treatment of adults].
Gruber A; Björkholm M
Addendum: BLOOD. 1996;88(10):4083
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage (vol 87, pg 3360, 1996)
Scuderi R; Palucka KA; Pokrovskaja K; Bjorkholm M; Wiman KG; Pisa P
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17:S63-S64
Intensive treatment in order to minimize the Ph-positive clone in CML
Simonsson B; Oberg G; Bjoreman M; Bjorkholm M; Carneskog J; Gahrton G; Hast R; Karl H; LanngNielsen J; Lofvenberg E; Malm C; Turesson I; Uden AM; Vilen L; WeisBjerrum O
Review: MEDICAL ONCOLOGY. 1996;13(1):63-69
Infections in neutropenic patients .2. Management
Engervall P; Bjorkholm M
Review: MEDICAL ONCOLOGY. 1995;12(4):251-256
Infections in neutropenic patients .1. Aetiology
Engervall P; Bjorkholm M
Other: LEUKEMIA RESEARCH. 1995;19(10):757-761
PHARMACOKINETICS OF MITOXANTRONE, ETOPOSIDE AND CYTOSINE-ARABINOSIDE IN LEUKEMIC-CELLS DURING TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP TO TREATMENT OUTCOME AND BONE-MARROW TOXICITY
GRUBER A; LILIEMARK E; TIDEFELT U; PAUL C; BJORKHOLM M; PETERSON C; LILIEMARK J
Other: INTERNATIONAL JOURNAL OF HEMATOLOGY. 1995;62(2):117-120
SUCCESSFUL INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR SEVERE AND PERSISTENT ASTROVIRUS GASTROENTERITIS AFTER FLUDARABINE TREATMENT IN A PATIENT WITH WALDENSTROMS MACROGLOBULINEMIA
BJORKHOLM M; CELSING F; RUNARSSON G; WALDENSTROM J
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;54(5):334-335
FLUDARABINE AND PLASMA-CELL LEUKEMIA
BJORKHOLM M; OSBY E
Review: ADVANCES IN PROSTAGLANDIN, THROMBOXANE, AND LEUKOTRIENE RESEARCH. 1995;23:293-298
THE 5-LIPOXYGENASE PATHWAY IN NORMAL AND MALIGNANT HUMAN B-LYMPHOCYTES
JAKOBSSON PJ; LARSSON P; FELTENMARK S; ODLANDER B; RUNARSSON G; BJORKHOLM M; CLAESSON HE
Show more

Employments

Professor Emeritus, Department of Medicine, Karolinska Institutet, 2025-2026
Professor, Senior, Department of Medicine, Karolinska Institutet, 2024-2025
Professor, Department of Medicine, Karolinska Institutet, 2020-2024
Professor, Senior, Department of Medicine, Karolinska Institutet, 2015-2020
Professor/Senior Physician, Department of Medicine, Karolinska Institutet, 1996-2015
Professor, Department of Medicine, Karolinska Institutet, 1995-1995

Degrees and Education

Docent, Serafimerlasarettet, 1979

Supervision

Supervision to doctoral degree
- Enoch Chen, Extrapolating survival with applications in health technology assessment, 2021-
- Caroline Weibull, Survivorship in Hodgkin lymphoma : childbearing and treatment-related disease, https://openarchive.ki.se/xmlui/handle/10616/46467, 2018
- Sandra Eloranta, Development and application of statistical methods for population-based cancer patient survival, https://openarchive.ki.se/xmlui/handle/10616/41612, 2013

Articles

All other publications

Employments

Degrees and Education

Supervision

Supervision to doctoral degree

News from KI

Events from KI